 |
|
 |
| |
 |
|
Class Information
Number: 424/437
Name: Drug, bio-affecting and body treating compositions > Preparations characterized by special physical form > Implant or insert > Otic
Description: Subject matter in which the special physical form is intended and adapted for placement in the ear canal.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5554388 |
Systemic drug delivery compositions comprising a polycationi substance |
Sep. 10, 1996 |
| 5540930 |
Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Jul. 30, 1996 |
| 5503848 |
Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery |
Apr. 2, 1996 |
| 5492937 |
Gel-forming liquid carrier composition |
Feb. 20, 1996 |
| 5489435 |
Composition for treatment of abnormal conditions of the epithelium of bodily orifices |
Feb. 6, 1996 |
| 5468811 |
Hydrophilic composite polymer articles formed from a settable paste comprising a mixture of hydrophilic polymer and unsaturated monomer |
Nov. 21, 1995 |
| 5401806 |
Biocompatible mouldable polymeric material |
Mar. 28, 1995 |
| 5350580 |
Device and method for extended delivery of pharmacologically active agents to the ear |
Sep. 27, 1994 |
| 5346703 |
Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
Sep. 13, 1994 |
| 5178873 |
Essential fatty acid treatment |
Jan. 12, 1993 |
| 5156842 |
Liquid suspension for oral administration |
Oct. 20, 1992 |
| 5143731 |
Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
Sep. 1, 1992 |
| 5130137 |
Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
Jul. 14, 1992 |
| 5126127 |
Stabilized PVP-I solutions |
Jun. 30, 1992 |
| 5093127 |
Preparation of FR115224 substrate for parenteral administration |
Mar. 3, 1992 |
| 5057319 |
Pharmaceutical compositions of cimetidine |
Oct. 15, 1991 |
| 4994273 |
Solubility modulated drug delivery device |
Feb. 19, 1991 |
| 4968633 |
Mucosal allergo-test and relevant device for the determination of specific and total IgE |
Nov. 6, 1990 |
| 4952402 |
Controlled release powder and process for its preparation |
Aug. 28, 1990 |
| 4923700 |
Artificial tear suspension |
May. 8, 1990 |
| 4923699 |
Eye treatment suspension |
May. 8, 1990 |
| 4609374 |
Osmotic device comprising means for governing initial time of agent release therefrom |
Sep. 2, 1986 |
| 4322323 |
Erodible device comprising surfactant for modifying the rate of erosion of the device |
Mar. 30, 1982 |
| 4298003 |
System for delivering agent at zero order rate with emerging agent below saturation |
Nov. 3, 1981 |
| 4256108 |
Microporous-semipermeable laminated osmotic system |
Mar. 17, 1981 |
| 4160452 |
Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
Jul. 10, 1979 |
| 4138344 |
Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) |
Feb. 6, 1979 |
| 4036228 |
Osmotic dispenser with gas generating means |
Jul. 19, 1977 |
| 3968201 |
Dosage unit containing a substance showing a topical effect on the eye, and a method of preparing same |
Jul. 6, 1976 |
| 3948254 |
Novel drug delivery device |
Apr. 6, 1976 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
